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Figure S1. A PTFE-based flow reactor (right) and a Thales Nano’s H-Cube (left) were used in this 
study. HPLC pumps delivered reactants into the tubular reactor, immersed in an oil bath, set at the 
desired working temperature. The in situ hydrogen gas generating capability of the H-Cube unit was 
deactivated during the experiments.  
 
 
 
 
 
 
Figure S2. Screening of the mono-alkylation reaction of tert-Butyl N-(6-aminohexyl)carbamate 3 
(40 mM in MeCN with 3 equiv DIPEA) with benzyl 2-bromoacetate (1 equiv, 40 mM in MeCN) 
under continuous flow conditions for the optimal residence time (3 vs. 5 min) and temperature (80–
130 oC) (n = 3, variation in yields within ±3%). HPLC conversion (detection at 254 nm) refers to the 
formation of the mono-alkylated compound 4. 
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Scheme S1. Synthesis of fluorescein-labelled hybrid peptoids H5, H7 and H9. (a) Deprotection; up to 7mer sequences on the resins: 20% 
piperidine in DMF (2 × 60 °C, 10 min, µwave); 8mer and above: 4% DBU–piperidine (1:1) DMF (60 °C, 10 min, µwave) followed by 8% 
DBU–piperidine (1:1) in DMF (60 °C, 10 min, µwave) (b) Coupling; monomer 1 or 2 (2 equiv), DIC (2 equiv), Oxyma (2 equiv) at 0.14 M in 
DMF–DCM (3:1), µwave, 70 °C, 25 min; (c) Coupling; N-Fmoc-6-aminohexanoic acid (2 equiv), otherwise as in (b); (d) 5(6)-
carboxyfluorescein (2 equiv), otherwise as in (b); (e) Cleavage and deprotection; TFA with 2.5% TIS and 2.5% H2O, rt, 3 h. 
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Figure S3. Cytotoxicity studies of the peptoids L5– L9, T5– T9 and H5–H9 on HeLa cells at 10 µM 
concentration. (A) MTT assay (n = 3). Absorbance was measured at 570 nm. (B) PI cell viability 
assay (n = 2). Fluorescence was measured via flow cytometry (λEx/Em 535/ 617 nm). 
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Experimental 
 
1. General Information 
All solvents, reagents and resins were obtained from commercial suppliers and used without 
purification, unless otherwise stated. 1H and 13C NMR spectra were recorded on an automated 
BrukerAVA500 spectrometer (500 and 125 MHz, respectively) in the indicated solvents at 298 K. 
Chemical shifts (δ) are quoted in parts per million (ppm) relative to the residual solvent. IR spectra 
were recorded using neat samples on a BrukerTensor 27 FT-IR spectrometer with significant 
functional group frequencies reported in cm-1.  
ESI-MS analysis was performed on an Agilent 1100 series LC-MS system. Mass spectra were 
acquired via a VG Platform Single Quadrupole ESI mass spectrometer. High resolution MS was 
performed using Bruker 3.0 T Apex II spectrometer. Analytical HPLC was conducted on an Agilent 
1100 series HPLC system, equipped with Supelco’s Discovery® C18 (50 mm × 2.1 mm × 5 µm) 
column, with UV detection at 254 and 495 nm in conjunction with Evaporative Light Scattering 
detection (ELSD) (PolymerLab PL-ELS1000E).  
 
2. Flow Instrumentation  
 
The flow experiments were performed on a self-assembled continuous flow set-up, coupled to a H-
Cube unit with the H2 gas generation capability switched off (see Figure S1). Three HPLC pumps 
(Knauer Smartline Pump 100 (2 units) and Waters 515 HPLC Pump) were used to deliver the 
reactants continuously into the flow reactor. A PEEK T-mixer (0.80 mm internal bore) was used to 
mix two separate feed streams and the mixture was channelled into the flow reactor. The coil reactor 
was made of PTFE tubing (0.50 mm I.D.) with an internal volume of 4 or 8 mL. In order to perform 
reactions at elevated temperatures, an adjustable back pressure regulator (BPR) [PEEK housing, 
spring-loaded FFKM diaphragm, polyimide membrane, 1–20 bar operating pressure] was installed to 
pressurise the flow system. Standard HPLC fittings were used to connect each individual component 
to create a fully functional reaction platform.  
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3. Flow synthesis 
 
3.1 Selective Mono-Alkylation of Mono-Boc Protected Diamine (Flow Screening) 
 
N-Boc-1,6-diaminohexane 3  (40 mM, 20 µmol scale) and base (3.0 equiv, 60 µmol scale) in MeCN 
(0.5 mL), along with benzyl 2-bromoacetate (40 mM, 20 µmol scale) in MeCN (0.5 mL) were fed 
continuously into a PTFE reactor (0.50 mm I.D., 2 mL total volume) immersed in an oil bath set to 
the desired working temperature (80–130 oC) and pressurised to 2 bar. The reactants were introduced 
via their respective pre-conditioning segments (PTFE tubing, 0.5 mm I.D., 0.2 mL volume) 
immersed in a temperature adjusted bath. The reactants converged in the T-mixer and the residence 
time of the reaction (3 or 5 min) was determined by adjusting the total flow rate of the HPLC pump-
driven reaction stream.  The reaction stream (1 mL) was collected at steady state after 1.5 reactor 
volume, into a vial filled with cold MeCN (4 mL, -20 oC) containing an excess of Trisamine-Si 
scavenger (13 mg, 20 µmol) under stirring and subsequently, filtered off. An aliquot of the diluted 
solution (100 µL) was sampled and added to an internal standard solution (methyl benzoate, 1 mM, 
100 µL) and analysed via HPLC. The individual components (product, side product and internal 
standard) in the solution were monitored with UV detection at 254 nm and the integrated areas of 
their respective peaks were obtained. The product 4 yield, and product 4 to side product 6 ratio were 
established based on the following equation:  
 
 
 
 
where DRFProduct (Detector Response Factor of 4) = 0.173 
DRFSide Product (Detector Response Factor of 6) = 0.540  
  
Product deProduct/Si
Product deProduct/Si
Product deProduct/Si DRF
Conc.
Area
Area
.Conc IS
IS
×=
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3.2 Tandem Alkylation and Fmoc Carbamation in Flow (Scale Out) 
 
Scheme S2. Tandem alkylation and Fmoc carbamation under continuous flow conditions. 
 
Mono-Boc diamine 3 or 8 (40 mM, 4.9 mmol) and DIPEA (2.6 mL, 14.7 mmol) in MeCN (123 mL), 
along with benzyl 2-bromoacetate (40 mM, 0.8 mL, 4.9 mmol) in MeCN (123 mL) were fed 
continuously into a PTFE reactor (0.50 mm I.D., 4 mL total volume) immersed in an oil bath set at 
100 oC and pressurised to 2 bar. The reactants were introduced via their respective pre-conditioning 
segments (100 oC) [PTFE tubing, 0.5 mm I.D., 0.18 mL volume]. The reactants converged in the T-
mixer and the total flow rate of reaction stream was fixed at 1.33 mLmin-1 to give a residence time of 
       S8 
3 min. Post back pressure regulator, the reaction stream was connected to a stainless steel scavenger 
column (0.5 × 6.0 cm, d × l) packed with Trisamine-Si scavenger (0.62 g, 0.98 mmol). The exiting 
reaction stream (cooled via a segment of PTFE tubing immersed in water bath) and Fmoc-Cl (0.97 g, 
3.8 mmol) in MeCN (15 mM, 250 mL) was immediately fed into another PTFE reactor (0.50 mm 
I.D., 8 mL total volume) immersed in water bath set at 25 oC. The reactants converged in the second 
T-mixer and the total flow rate of reaction stream was fixed at 2.66 mLmin-1, to give a residence time 
of 3 min. The reaction stream (492 mL) was collected at steady state after 1.5 reactor volume, into a 
flask filled with cold MeCN (200 mL, −20 oC) under stirring and concentrated in vacuo. The crude 
mixture was purified via flash column chromatography (silica gel, 60:40 hexane– EtOAc) to give 5  
or 9. The intermediate products 4 and the mono-alkylated TEG analogue 10 were also isolated and 
are reported here for characterisation.  
 
 
Benzyl 2-[(6-{[(tert-butoxy)carbonyl]amino}hexyl)[(9H-fluoren-9-yl methoxy) 
carbonyl]amino]acetate (5) 
 
 
 
Yield 1.98 g (69%); yellow oil. IR (neat): ν (cm-1) = 3371, 2932, 2854, 1739, 1705, 1682, 1524, 
1446, 1195, 1168; 1H NMR (500 MHz, CDCl3) two rotamers: δ [ppm] = 1.24–1.27 [m, 4H, 
R’(CH2)2R’’], 1.44–1.45 [m, 9H, Boc-H], 1.60 [s, 4H, CH2 × 2], 3.08–3.09 (m, 2H, CH2NHBoc), 
3.14 and 3.32 [t, J = 7.6 Hz, 2H, R’N(Fmoc)CH2R’’], 3.94 and 4.01 [s, 2H, R’CH2N(Fmoc)R’’], 
4.25 (t, J = 6.1 Hz, 1H, CH-9), 4.38 and 4.51 (d, J = 6.4 Hz, 2H, RCH2CH-9), 5.11 and 5.16 (s, 2H, 
Bn-H), 7.28–7.41 (m, 9H, Ph-H and CH-2/7 and CH-3/6), 7.51 and 7.57 (d, J = 7.5 Hz, 2H, CH-1/8), 
7.73–7.79 (m, 2H, CH-4/5); 13C NMR (125 MHz, CDCl3): two rotamers δ [ppm] = 26.23, 26.38 and 
26.49, 27.79, 28.22 (alkyl bridge), 28.42 [C(CH3)3], 29.88 and 29.98 (alkyl bridge), 40.44 
(CH2NHBoc), 47.24 and 47.25 (CH-9), 48.75 and 48.81 [R’N(Fmoc)CH2R’’], 50.35 
[R’CH2N(Fmoc)R’’], 66.91 (RCH2CH-9), 67.29 and 67.55 (PhCH2), 126.97 (CH-3/6), 127.01 and 
127.07, 127.58 and 127.63 (C6H5), 128.30 (CH-2/7), 128.37 (CH-4/5), 128.45 (CH-1/8), 128.55 and 
128.58 (C6H5), 141.26 and 141.37 (CH-4a/4b), 141.51 (C6H5), 143.93 and 143.97 (CH-8a/9a), 
155.86 and 155.96 (CO2CH2CH-9), 156.45 (CO2tert-Bu), 169.49 and 169.58 [BnOC(O)R]; LC-MS 
N
N
H
OO
OO
OO
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(ESI+): m/z (%) = 587.4 (51) [M+H]+; 609.4 (97) [M+Na]+; HR-MS (C35H42N2O6): calc: 586.3037; 
found: 586.3043. Spectral data are consistent with the literature.I 
 
Benzyl 2-(12-{[(tert-butoxy)carbonyl]amino}-1-(9H-fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-
azadodecan-4-yl)acetate (9) 
 
 
 
 
Yield: 1.87 g (62%); yellow oil. IR (neat): ν (cm-1) = 3352, 2867, 1747, 1702, 1501, 1451, 1364, 
1244, 1173, 1139, 1001; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 1.43 (s, 9H, Boc-H), 
3.27–3.28 (m, 2H, CH2NHBoc), 3.34–3.41 and 3.46–3.50 (m, 8H, ether bridge), 3.56–3.58 and 3.61–
3.63 [m, 2H, R’N(Fmoc)CH2R’’], 4.12–4.13 [m, 2H, R’CH2N(Fmoc)R’’], 4.25 (t, J = 6.1 Hz, 1H, 
CH-9), 4.37 and 4.51 (d, J = 6.5 Hz, 2H, RCH2CH-9), 4.96–5.00 (m, 1H, NH), 5.11 and 5.15 (s, 2H, 
Bn-H), 7.25–7.41 (m, 9H, Ph-H and CH-2/7 and CH-3/6), 7.51 and 7.57 (d, J = 7.4 Hz, 2H, CH-1/8), 
7.75 (t, J = 8.1 Hz, 2H, CH-4/5); 13C NMR (125 MHz, CDCl3): two rotamers δ [ppm] = 28.40 
[C(CH3)3], 40.28 (CH2NHBoc), 47.17 and 47.22 (CH-9), 48.46 [R’N(Fmoc)CH2R’’], 50.13 and 
50.26 [R’CH2N(Fmoc)R’’], 66.82 (RCH2CH-9), 67.46 and 67.71 (PhCH2), 70.06 and 70.11, 70.21, 
70.23 and 70.25, 70.33 and 70.35 (ether bridge), 124.82 and 124.91 (CH-3/6), 127.02 and 127.09, 
127.64 and 127.67 (C6H5), 128.27 (CH-2/7), 128.35 (CH-4/5), 128.41 (CH-1/8), 128.58 (C6H5), 
141.26 and 141.35 (CH-4a/4b), 143.88 and 143.93 (CH-8a/9a), 155.95 (CO2CH2CH-9), 156.17 
(CO2tert-Bu), 169.64 and 169.70 [BnOC(O)R]; LC-MS (ESI+): m/z (%) = 619.3 (25) [M+H]+; 641.4 
(100) [M+Na]+; HR-MS (C35H42N2O8): calc: 618.2936; found: 618.2933.  
 
Benzyl 2-[(6-{[(tert-butoxy)carbonyl]amino}hexyl)amino]acetate (4) 
 
 
 
 
Yellow oil; IR (neat): ν (cm-1) = 3361, 2929, 2857, 1687, 1518, 1389, 1167; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.29–1.32 [m, 4H, R’(CH2)2R’’], 1.43 [s, 9H, Boc-H], 1.46–1.49 [m, 4H, CH2 × 
N
O
O
O
O
N
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O
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OO
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2], 2.58 (t, J = 7.2 Hz, 2H, R’NHCH2R’’), 3.09–3.10 (m, 2H, CH2NHBoc), 3.44 (s, 2H, 
R’CH2NHR’’), 4.53 (br s, 1H, NH), 5.16 (s, 2H, Bn-H), 7.30–7.38 (m, 5H, Ph-H); 13C NMR (125 
MHz, CDCl3): δ [ppm] = 26.58, 26.81 (alkyl bridge), 28.40 [C(CH3)3], 29.88, 29.94 (alkyl bridge), 
40.47 (CH2NHBoc), 49.43 (R’NHCH2R’’), 50.92 (R’CH2NHR’’), 66.52 (PhCH2), 79.02 [C(CH3)3], 
128.34, 128.37, 128.58 and 135.59 (C6H5), 155.97 [CO2tert-Bu], 172.45 (BnOC(O)R CO2Bn); LC-
MS (ESI+): m/z (%) = 365.3 (99) [M+H]+; 387.3 (5) [M+Na]+; HR-MS (C20H32N2O4): calc: 
364.2357; found: 364.2359. Spectral data are consistent with the literature.I 
 
Benzyl 2-({2-[2-(2-{[(tert-butoxy)carbonyl]amino}ethoxy)ethoxy]ethyl}amino) acetate (10) 
 
 
 
 
 
Yellow oil; IR (neat): ν (cm-1) = 3335, 2867, 1705, 1517, 1365, 1249, 1172; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.43 [s, 9H, Boc-H], 2.82 (t, J = 5.2 Hz, 2H, R’NHCH2R’’), 3.30– 3.31 (m, 2H, 
CH2NHBoc), 3.50 (s, 2H, R’CH2NHR’’), 3.52 (t, J = 5.1 Hz,  2H, ether bridge), 3.58–3.60 (m, 6H, 
ether bridge), 5.16 (s, 2H, Bn-H), 7.31–7.38 (m, 5H, Ph-H); 13C NMR (125 MHz, CDCl3): δ [ppm] = 
28.40 [C(CH3)3], 40.35 (CH2NHBoc), 48.69 (R’NHCH2R’’), 50.89 (R’CH2NHR’’), 66.49 (PhCH2), 
70.13, 70.23 and 70.69 (ether bridge), 79.09 [C(CH3)3], 128.34, 128.57 and 135.61 (C6H5), 156.02 
(CO2tert-Bu), 172.23 [BnOC(O)R]; LC-MS (ESI+): m/z (%) = 397.2 (99) [M+H]+; 419.2 (26) 
[M+Na]+; HR-MS (C20H32N2O6): calc: 396.2255; found: 396.2266. Spectral data are consistent with 
the literature.II 
 
 
3.3 Catalytic Transfer Hydrogenolysis of the Benzyl Group 
 
3.3.1 Flow Screening  
 
Fmoc protected benzyl acetate 5 (7.5 µmol) and 1,4-cyclohexadiene (2.5 equiv) in EtOH were 
prepared at different concentrations (15, 30 or 50 mM) and fed continuously into a H-Cube unit 
(generation of H2 gas was deactivated). The catalyst compartment was fitted with the catalyst of 
choice (CatCart’s 10% Pd/C or 20% Pd(OH)2/C cartridge) and the desired working temperature was 
adjusted accordingly (25 or 40 oC), with the reaction stream flow rate set at 1.00 mLmin-1. The 
reaction stream (1 mL) was collected at steady state after 1.5 minutes, into a vial filled with cold 
H
N
O
O
O
O
N
H
O
O
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EtOH (4 mL, −20 oC) under stirring. An aliquot of the diluted solution (100 µL) was sampled and 
added to an internal standard solution (1 mM aniline, 100 µL) and analysed via HPLC. The 
individual components (starting material, product and internal standard) in the solution were 
monitored with UV detection at 254 nm and the integrated areas of their respective peaks were 
obtained. The product 1 yield and product to side product (1:7) ratio were established based on the 
following equation: 
 
 
where DRFProduct (Detector Response Factor of 1) = 48.417  
 
 
3.3.2 General Scale-Out Procedure  
 
 
 
Scheme S3. Catalytic transfer flow hydrogenolysis. 
 
Compound 5 (3.4 mmol) or 9 (3.0 mmol) [15 mM] and 1,4-cyclohexadiene (0.8 mL, 8.5 mmol) in 
EtOH (227 / 200 mL) were fed continuously into a H-Cube unit, which had the generation of H2 gas 
deactivated. The catalyst compartment was fitted with CatCart’s 20% Pd(OH)2/C cartridge (3.0 × 0.4 
cm, loading ~150 mg/cartridge), and the desired working temperature was set at 40 oC with a flow 
rate of 1.00 mLmin-1. The reaction stream was collected at steady state after 1.5 minutes, into a flask 
filled with cold EtOH (100 mL,  –20  oC) under stirring and concentrated in vacuo. The crude 
mixture was dissolved in EtOAc (50 mL) and washed with brine (3 × 50 mL). The organic layer was 
concentrated in vacuo and and purified by flash column chromatography (silica gel, 90:10 DCM–
MeOH with 0.1% AcOH) to give a viscous yellow oil, which was subsequently recrystallised using 
hexane–EtOAc to give compound 1 or 2. 
 
 
 
 
 
 
Product
Product
Product DRF
Conc.
Area
Area
.Conc IS
IS
×=
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2-[(6-{[(tert-Butoxy)carbonyl]amino}hexyl)[(9H-fluoren-9-ylmethoxy)carbonyl]amino]acetic 
acid (1) 
 
 
 
Yield 1.18 g (70%); white solid. M.p. 80–82 oC; IR (neat): ν (cm-1) = 3359, 2978, 2930, 2851, 1728, 
1680, 1519, 1416, 1367, 1168, 960, 918; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 1.21– 
1.34 [m, 8H, R’(CH2)4R’’], 1.44 [s, 9H, Boc-H], 3.08–3.09 (m, 2H, CH2NHBoc), 3.13 and 3.33 [t, J 
= 7.2 Hz, 2H, R’N(Fmoc)CH2R’’], 3.90 and 3.98 [s, 2H, R’CH2N(Fmoc)R’’], 4.20–4.25 (m, 1H, 
CH-9), 4.43 and 4.54 (d, J = 5.3 Hz, 2H, RCH2CH-9), 7.27 – 7.32 (m, 2H, CH-2/7), 7.36 – 7.41 (m, 
2H, CH-3/6), 7.57 (t, J = 8.7 Hz, 2H, CH-1/8), 7.75 (t, J = 8.1 Hz, 2H, CH-4/5); 13C NMR (125 
MHz, CDCl3): two rotamers δ [ppm] = 25.96 and 26.15, 26.21 and 26.31, 27.76 and 28.09 (alkyl 
bridge), 28.41 [C(CH3)3], 29.69 (alkyl bridge), 40.40 (CH2NHBoc), 47.26 (CH-9), 48.53 and 48.78 
[R’N(Fmoc)CH2R’’], 50.35 [R’CH2N(Fmoc)R’’], 67.39 and 67.70 (RCH2CH-9), 79.33 [C(CH3)3], 
124.77 and 124.93 (CH-3/6), 127.05 (CH-2/7), 127.61 (CH-4/5), 127.67 (CH-1/8), 141.30 and 
141.38 (CH-4a/4b), 143.87 and 143.93 (CH-8a/9a), 155.96 (CO2CH2CH-9), 156.78 (CO2tert-Bu), 
172.63 [BnOC(O)R]; LC-MS (ESI+): m/z (%) = 519.3 (38) [M+Na]+; HR-MS (C28H36N2O6): calc: 
496.2568; found: 496.2560. Spectral data are consistent with the literature.I  
 
2-(12-{[(tert-Butoxy)carbonyl]amino}-1-(9H-fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-azadodecan-4-
yl)acetic acid (2) 
 
 
 
Yield: 1.07 g (68%); yellow oil. IR (neat): ν (cm-1) = 2870, 2248, 1692, 1511, 1476, 1451, 1409, 
1365, 1244, 1139, 998, 909; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 1.44 [s, 9H, Boc-
H], 3.30–3.67 (m, 12H, ether bridge), 4.1 (s, 2H, R’CH2N(Fmoc)R’’), 4.21–4.26 (m, 1H, CH-9), 
4.38 and 4.52 (br s, 2H, RCH2CH-9), 5.09 (br s, 1H, NH), 7.29–7.32 (m, 2H, CH-2/7), 7.36–7.41 (m, 
2H, CH-3/6), 7.57 (d, J = 7.4 Hz,  CH-1/8), 7.75 (t, J = 6.8 Hz, 2H, CH-4/5); 13C NMR (125 MHz, 
N
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CDCl3): two rotamers δ [ppm] = 28.40 [C(CH3)3], 40.26 (CH2NHBoc), 47.16 and 47.21 (CH-9), 
48.40 [R’N(Fmoc)CH2R’’], 50.59 [R’CH2N(Fmoc)R’’], 67.44 (RCH2CH-9), 67.99, 69.98, 70.07, 
70.25 (ether bridge), 124.81 (CH-3/6), 125.07 (CH-2/7), 127.07 (CH-4/5), 127.62 (CH-1/8), 141.23 
and 141.34 (CH-4a/4b), 143.90 (CH-8a/9a), 156.02 (CO2CH2CH-9), 156.19 (CO2tert-Bu), 172.27 
and 172.44 [HOC(O)R]; LC-MS (ESI+): m/z (%) = 529.3 (32) [M+H]+; 551.3 (99) [M+Na]+; HR-
MS (C28H36N2O8): calc: 528.2466; found: 528.2464.  
 
4. Solid Phase Synthesis of Peptoids 
All the coupling reactions were performed in peptide grade DMF. Microwave reactions were carried 
out with Biotage Initiator Microwave Synthesiser operating at 2.45 GHz. To enable rapid and 
convenient analysis of the progress of the coupling and deprotecction reactions, qualitative ninhydrin 
or chloranil test were used. The peptoids were analyzed by analytical HPLC. Elution was performed 
with (A) 0.1% formic acid in HPLC-grade deionised water and (B) 0.1% formic acid in HPLC-grade 
MeCN: at 1 mLmin-1 with a gradient of 5 to 95% B over 3 min, followed by 2 min isocratic at 95% 
B and ending with a gradient of 95 to 5% B over 1 min. For the analysis of the peptoids see Table S1 
below. 
 
Rink Amide Functionalisation of Aminomethyl Polystyrene Resin 
4-[(2,4-Dimethoxyphenyl)(Fmoc-amino)methyl]phenoxyacetic acid (Rink-linker) (0.60 g, 1.1 mmol, 
3 equiv) and ethyl 2-cyano-2-(hydroxyimino)acetate (Oxyma) (0.16 g, 1.1 mmol, 3 equiv) were 
dissolved in DMF (0.37 M, 3 mL) and shaken for 5–10 min. DIC (0.17 mL, 1.1 mmol, 3 equiv) was 
added to the mixture and shaken for 2 min. The mixture was added to the aminomethyl PS resin 
(0.30 g, 0.37 mmol, 1% DVB, 100–200 mesh, loading 1.23 mmol/g) and shaken for 1.5 h at room 
temperature. After filtration, the resin was washed with DMF, DCM and MeOH (× 3 each).  
 
Solid Phase Synthesis of Lysine-like Peptoids L5, L7 and L9 
Fmoc-Rink amide functionalised PS resin (60 mg, 44 µmol) was treated with 20% piperidine in 
DMF (1 mL, 2 × 15 min). After filtration, the resin was washed with DMF and DCM (× 3 each). 
Monomer 1 (44 mg, 89 µmol, 2 equiv) and Oxyma (13 mg, 89 µmol, 2 equiv) were dissolved in 
DMF (0.15 M, 0.60 mL) and shaken for 5–10 min. DIC (0.17 mL, 1.1 mmol, 2 equiv) was added and 
the mixture shaken for 2 min. The mixture was added to the deprotected resin (60 mg, 44 µmol) and 
the resin was shaken for 30 min at room temperature for the first 5 residues.  For oligomers with > 5 
residues on the resin, the coupling reactions were heated to 60 °C in a water bath for 15 min 
followed by a 15 min of shaking at room temperature. After each coupling, the resin was washed 
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with DMF, DCM and MeOH (× 3 each) followed by deprotection with 20% piperidine in DMF (1 
mL, 2 × 15 min).  After the desired oligomer length was achieved, N-Fmoc-6-aminohexanoic acid 
(31 mg, 89 µmol, 2 equiv) was coupled to the N-terminus, followed by 5(6)-carboxyfluorescein (33 
mg, 89 µmol, 2 equiv). The coupling and Fmoc deprotection conditions were as previously stated.  
 
Solid Phase Synthesis of TEG-based Peptoids T5, T7 and T9 
The Fmoc-Rink amide-functionalised PS resin (60 mg, 44 µmol) was treated with 20% piperidine in 
DMF (1 mL, 2 × 15 min). After filtration, the resin was washed with DMF and DCM (× 3 each). 
Monomer 2 (47 mg, 89 µmol, 2 equiv) and Oxyma (13 mg, 89 µmol, 2 equiv) were dissolved in 
DMF–DCM (3:1) (0.14 M, 0.63 mL) and shaken for 5–10 min. DIC (0.17 mL, 1.1 mmol, 2 equiv) 
was added and the mixture and shaken for another 2 min. The mixture was added to the deprotected 
resin (60 mg, 44 µmol) and microwave irradiated for 25 min at 70 °C. After each coupling, the resin 
was washed with DMF, DCM and MeOH (× 3 each). The Fmoc group was deprotected by treating 
the resin twice with 20% piperidine in DMF (1 mL) under microwave irradiation at 60 °C for 10 min. 
The coupling and deprotection protocols was repeated until the desired oligomer length was achieved, 
after which N-Fmoc-6-aminohexanoic acid (31 mg, 89 µmol, 2 equiv) was coupled to the N-terminus, 
followed by 5(6)-carboxyfluorescein (33 mg, 89 µmol, 2 equiv). The coupling and Fmoc 
deprotection conditions were as previously stated.  
 
Solid Phase Synthesis of Hybrid  Peptoids H5, H7 and H9 
The Fmoc-Rink amide-functionalised PS resin (60 mg, 44 µmol) was treated with 20% piperidine in 
DMF (1 mL, 2 × 15 min). After filtration, the resin was washed with DMF and DCM (× 3 each). 
Monomer 1 or 2 (89 µmol, 2 equiv) and Oxyma (13 mg, 89 µmol, 2 equiv) were dissolved in DMF– 
DCM (3:1) (0.14 M, 0.63 mL) and and shaken for 5–10 min. DIC (0.17 mL, 1.1 mmol, 2 equiv) was 
added and the mixture and shaken for another 2 min. The mixture was added to the deprotected resin 
(60 mg, 44 µmol) and microwave irradiated for 25 min at 70 °C. After each coupling, the resin was 
washed with DMF, DCM and MeOH (× 3 each). The Fmoc deprotection procedure with 20% 
piperidine in DMF was performed twice under microwave irradiation at 60 °C for 10 min up to 7 
residues on the resin, after which the deprotection solution was changed to DBU–piperidine (4% 
each) in DMF. The couplings (performed using 1 or 2 in successive manner) and deprotection 
protocols were repeated until the desired oligomer length was achieved. N-Fmoc-6-aminohexanoic 
acid (31 mg, 89 µmol, 2 equiv) was coupled to the N-terminus, followed by 5(6)-carboxyfluorescein 
(33 mg, 89 µmol, 2 equiv). The coupling and Fmoc deprotection conditions were as previously stated. 
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Cleavage from the Resin and Purication of the Peptoids 
The peptoids were cleaved from the solid support and deprotected with 1 mL of TFA–TIS–H2O 
(95:2.5:2.5) for 3 h at room temperature. The solution was drained from the solid support cartridge 
and the resin washed twice with the cleavage solution. The combined filtrates were concentrated 
with N2 (g) to a minimal volume, 1 mL of cold Et2O (L5, L7 and L9) or petroleum ether (T5, T7 and 
T9 and H5, H7 and H9) was added, and the product collected by centrifugation at 4 °C (104 rpm for 
10 min). The product was washed with fresh Et2O or petroleum ether (2 × 1 mL) (solution sonicated 
before centrifugation.) The crude product was dried first with N2 (g) and left in the desiccator 
overnight. The crude peptoids were dissolved in H2O and purified by semi-preparative HPLC using 
Dionex’s Acclaim 120 column (C18, 5 µm, 120  Å, 4.6 × 150.0 mm) in a 30 minute gradient from 5 
to 95% MeCN  (with 0.1% formic acid in H2O) at a flow rate of 1.0 mLmin-1. 
 
Table S1 Analytical data for the synthesized peptoids. 
compound yield mass
a  HPLC tR (min)b purity 
calculated found ELSD 495 nm ELSD 
L5 40 mg (71%) 
C67H104N12O12 
1269.6159 
 
1269.8614 
 
2.56 
 
2.46, 2.64 
 
>98% 
L7 42 mg (60%) 
C83H136N16O14 
1582.0667 
 
1582.7013 
 
2.38, 2.47 
 
2.29, 2.39 
 
>98% 
L9 46 mg (55%) 
C99H168N20O16 
1894.5176 
 
1895.3915 
 
2.23 
 
2.12, 2.32 
 
>98% 
T5 29 mg (45%) 
C67H104N12O22 
1429.6099 
 
1429.7113 
 
2.50, 2.60 
 
2.41, 2.52 
 
>98% 
T7 34 mg (42%) 
C83H136N16O28 
1806.0583 
 
1806.2077 
 
2.31, 2.41 
 
2.22, 2.32 
 
>98% 
T9 37 mg (38%) 
C99H168N20O34 
2182.5068 
 
2183.4156 
 
2.19, 2.27 
 
2.10, 2.18 
 
>98% 
H5 7 mg (12%) 
C67H104N12O16 
1333.6135 
 
1333.8332 
 
2.58, 268 
 
2.49, 2.60 
 
>98% 
H7 6 mg (8%) 
C83H136N12O20 
1678.0631 
 
1679.0334 
 
2.39, 2.50 
 
2.31, 2.42 
 
>98% 
H9 4 mg (5%) 
C99H168N20O24 
2022.5128 
 
2023.5198 
 
2.27, 2.36 
 
2.18 
 
>98% 
a Established by MALDI-ToF bThe double peaks observed are isomers of 5(6)-carboxyfluorescein.  
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5. Biological experiments 
 
5.1. Cell Culture 
The cells were maintained in a humidified HERAcell 150 incubator (Heraeus) at 37 °C with 5% 
CO2. The cells were grown in DMEM (HeLa and HEK) or Ham’s F12 (CHO) media supplemented 
with 4 mM glutamine, 10 % FBS and 100 units/mL of penicillin/streptomycin in T75 cell culture 
flasks until 70–80 % confluence. The cells were harvested with 0.25% trypsin/EDTA and re-plated 
in 1:5 splitting ratio.  
 
5.2. Cellular Uptake Assays 
3 × 104 cells/well were seeded on 48-well plates and grown overnight. The media was removed, the 
cells washed with PBS, and the peptoids added in culture media at 10, 2.5 or 1 µM (n = 3). After 
incubation for the desired time period at 37 °C, the cells were washed twice with PBS, and detached 
with 0.25% trypsin/EDTA. The cells were collected in 2% FBS in PBS with Trypan Blue (0.04%), 
and analysed using a BD FACSAria® flow cytometer ((λEx/λEm 488/530 nm). Histograms were 
generated with Flowjo® 7.5.  
 
5.3. Confocal Microscopy  
4 × 105 cells (HeLa) were seeded onto poly-L-lysine coated glass coverslips (25 mm diameter) 
placed on a 6-well plate (n = 3). The next day, the media was removed and H7 added at 1 µM in 
media. After 12 h incubation, the cells were fixed with 4% paraformaldehyde in PBS and the nuclei 
stained with Hoechst-33342 (1% w/v in PBS). The cells were imaged by Leica SP5 Confocal 
Microscope (λEx 488 and 407 nm) and analysed using Leica software (LAS AF). 
 
5.4. Cell Viability Assays 
The cell viability was measured using an MTT cell proliferation assay as described previously.III 
Briefly, 1 × 104 cells/ well were seeded on 96-well plates and cultured overnight. The peptoids were 
added at 10 µM and the cells were incubated overnight. After the MTT assay, the absorbance at 570 
nm was measured using a Benchmark Bio-Rad 83 microplate reader at 570 nm using the Microplate 
Manager 4.0 software.  
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For the propidium iodide (PI) cell viability assay, 3 × 104 cells/well were seeded on 48-well plates. 
The next day, the media was removed, the peptoids added at 10 µM in corresponding culture media, 
and the cells incubated for 24 h. The cells were washed twice with PBS, detached with 0.25% 
trypsin/EDTA, and harvested in the fluorochrome solution (0.1% sodium citrate (w/v), 0.1% Triton 
X-100 (v/v) and 50 mg/L PI in distilled water) with 2% FBS. The samples were incubated for 1 hour 
at 4 °C and analysed by BD FACSAria® flow cytometer. 
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8. HPLC traces for L5–L9, T5–T9 and H5–H9 
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